Loading clinical trials...
Loading clinical trials...
Phase 1B Study of KCC Peptide Application in the Colon
Conditions
Interventions
Colon KCC Heptapeptide
Locations
1
United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
June 1, 2014
Primary Completion Date
July 1, 2016
Completion Date
August 1, 2016
Last Updated
April 4, 2017
NCT07446322
NCT02600949
NCT05919264
NCT07541924
NCT07536113
NCT07537491
Lead Sponsor
Danielle Kim Turgeon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions